Clinical trials
Recruiting Thrombotic Microangiopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Fondazione Luigi Villa | 1 |
| ITAC (Instituto de Trasplantes y Alta Complejidad) | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Maastricht University Medical Center | 1 |
| Omeros Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombotic Microangiopathies | 14 |
| Atypical Hemolytic Uremic Syndrome | 4 |
| Purpura, Thrombotic Thrombocytopenic | 3 |
| Autoimmune Diseases | 1 |
| Bronchiolitis Obliterans | 1 |
| Cardiovascular Diseases | 1 |
| Disseminated Intravascular Coagulation | 1 |
| Glomerulonephritis, Membranoproliferative | 1 |
| Hemolytic-Uremic Syndrome | 1 |
| Hemophilia A | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.